Skip to content

GlobalLawDBby GenieAI

Laws Search Sanctions Map Data Developers

Search the text of the law

Log in Get an API key

Laws Search Sanctions Map Data Developers

Log in Get an API key

The Global Law Database. Free to read, built for people and AI agents.

Explore

All laws
Search the text
Sanctions
Map of connections
Compare UK and EU

Developers

AI agents (MCP)
REST API
Bulk data
API keys

Coverage

United Kingdom
European Union
United States
Canada
Australia
France
Germany
Netherlands
Spain
Austria
Norway
Finland
Switzerland
Ireland

GlobalLawDB is made by GenieAI, London. It is not legal advice: check the official text before relying on it. Text comes from official publishers under their licences, listed on the Data page.

ThemeMatch my systemLightDark

European Union
Kingdom of Spain v European Commission (C-263/13 P)
Judgment
The appeal
Findings of the Court
53

Kingdom of Spain v European Commission (C-263/13 P)

Judgment of 24 Jun 2015law://eu/cjeu/2013/c-263-13/para_53@2026-11-10

53It follows from the second paragraph of Article 108 of Regulation No 1083/2006 that Article 100 of that regulation was applicable from 1 January 2007, including for programmes earlier than the period 2007 to 2013.

Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.

Key facts

Court: Court of Justice · First Chamber
Case: C-263/13 P · ECLI:EU:C:2015:415
Decided: 24 Jun 2015
Procedure: Action for annulment
Ruled invalid: 62010TJ0065
Applicant: Kingdom of Spain
Defendant: European Commission
Rapporteur: F. Biltgen
Advocate General: M. Szpunar
Bench: 5 judges
A. Tizzano, S. Rodin, A. Borg Barthet, M. Berger, F. Biltgen
Language: Spanish
Official: CURIA · EUR-Lex 62013CJ0263

Topics

European Regional Development Fund (ERDF)

History · 1 version

24 Jun 2015Reading

Connections

Interprets 1: Kingdom of Spain v European Commission (T-65/10)
Cited by 11: Lisa Ballmann v European Data Protection Board (T-183/23)2 provisions; Debregeas et associés Pharma (D & A Pharma) v European Commission and European Medicines Agency (C-291/22 P); Hypo Vorarlberg Bank AG, foremerly Vorarlberger Landes- und Hypothekenbank AG v Single Resolution Board (T-377/16, T-645/16, T-809/16); Portigon AG v Single Resolution Board (T-365/16); Banco Cooperativo Español, SA v Single Resolution Board (T-323/16); Hamas v Council of the European Union (T-308/18); Tilly-Sabco SAS v European Commission (C-183/16 P); Boomkwekerij van Rijn-de Bruyn BV v Community Plant Variety Office (T-767/14); European Commission v Kingdom of Spain (C-140/15 P)3 provisions; European Commission v Kingdom of Spain (C-139/15 P)3 provisions; Gugler France v Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) (T-674/13)
Cites 12: European Commission v Ireland and Others (C-89/08); Council Regulation (EEC) No 4253/88 of 19 December 1988, laying down provisions for implementing Regulation (EEC) No 2052/88 as regards coordination of the activities of the different Structural Funds between themselves and with the operations of the European Investment Bank and the other existing financial instruments; Council Regulation (EC) No 1083/2006 of 11 July 2006 laying down general provisions on the European Regional Development Fund, the European Social Fund and the Cohesion Fund and repealing Regulation (EC) No 1260/1999; Commission of the European Communities v Imperial Chemical Industries plc (ICI) (C-286/95); Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) v National Lottery Commission (C-530/12 P); Kingdom of Spain v European Commission (C-192/13 P); United Kingdom of Great Britain and Northern Ireland v Council of the European Communities (C-68/86); Commission of the European Communities v Solvay SA (C-287/95); Kingdom of Spain v European Commission (C-197/13 P); Kingdom of Spain v European Commission (C-429/13 P); Kingdom of Spain v European Commission (T-65/10); Kingdom of Spain v European Commission (C-513/13)